Get started
Author

Ondrej Novotny

Observed name: Novotný, Ondřej
ORCID: 0000-0002-7311-1778
Observed ORCID: 0000-0002-7311-1778
OpenAlex ID: A5071237143
Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeutics
2022 · Zofia Chrienova, David Rysanek, et al. · Frontiers in Aging Neuroscience · 22
STAT3 inhibitor Stattic and its analogues inhibit STAT3 phosphorylation and modulate cytokine secretion in senescent tumour cells
2023 · Romana Mikyskova, Olena Sapeg, et al. · Molecular Medicine Reports · 20
PDF
Discovery of a 6-Aminobenzo[b]thiophene 1,1-Dioxide Derivative (K2071) with a Signal Transducer and Activator of Transcription 3 Inhibitory, Antimitotic, and Senotherapeutic Activities
2024 · Patrik Oleksak, David Rysanek, et al. · ACS Pharmacology & Translational Science · 6
PDF
Abstract 5278: Immunological control by PARP inhibitors for successful immunotherapy in metastatic ovarian carcinoma
2024 · Peter Holicek, Sarka Vosahlikova, et al. · Cancer Research
STAT3 signalling pathway modulation and its impacts on cell phenotype, senescence and secretome.
2024 · Novotný, Ondřej · Digital Repository (National Repository of Grey Literature)
Abstract B054: Immunological control by PARP inhibitors for successful immunotherapy in metastatic ovarian carcinoma
2023 · Sarka Vosahlikova, Peter Holicek, et al. · Cancer Immunology Research
Senescent cells and their elimination by the immune system
2020 · Novotný, Ondřej · Digital Repository (National Repository of Grey Literature)
Works count: 7
Citation count: 48
H-index: 3
I10-index: 2
Year
Topic
Type